Drugs / Freeze Dried Plasma
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT04794348 | May 2021 → Mar 2022 | — | Teleflex | Withdrawn | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT07840352 | Oct 2027 → Apr 2031 expected | thrombotic disease | Teleflex | Not yet recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Freeze-Dried Plasma | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07840352 ↗ |
| Known as | FDP | “Freeze Dried Plasma (FDP)” NCT04794348 ↗ |
| Modality | Protein / enzyme biologic | “Biological: Freeze Dried Plasma (FDP)” NCT04794348 ↗ |
| Route | Intravenous | “FDP and FFP will be infused intravenously.” NCT04794348 ↗ |